Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.33% | $6.98M | €401.77B | 41.34% | 76 Outperform | |
| Novartis AG | 1.45% | $4.35M | CHF216.20B | 24.14% | 80 Outperform | |
| Roche Holding AG | 1.41% | $4.21M | CHF270.15B | 45.02% | 73 Outperform | |
| AstraZeneca | 1.40% | $4.20M | £220.54B | 29.01% | 80 Outperform | |
| Royal Bank Of Canada | 1.36% | $4.06M | $236.91B | 43.18% | 75 Outperform | |
| SAP SE | 1.23% | $3.68M | €237.28B | -15.64% | 66 Neutral | |
| Schneider Electric | 1.22% | $3.66M | €137.68B | -7.00% | 62 Neutral | |
| HSBC Holdings | 1.21% | $3.62M | £204.52B | 49.59% | 80 Outperform | |
| ABB Ltd | 1.06% | $3.16M | kr1.28T | 20.07% | 78 Outperform | |
| Allianz | 0.95% | $2.85M | €145.72B | 27.96% | 67 Neutral |